Browsing: Drug
The promise of breakthrough prescription drugs has created an sudden disaster in employer advantages. As GLP-1 medicines reveal exceptional efficacy…
It marks one other flip in Trump’s unpredictable commerce coverage, which has resulted in sweeping world tariffs and renewed brinkmanship…
adventtrThe Exscientia Experiment: When AI Meets Pharma Realities Exscientia’s (NASDAQ:EXAI) inventory is off 22% since my “Purchase” advice in August.…
ismagilov Stifel has began protection of newly public Lexeo Therapeutics (NASDAQ:LXEO) with a purchase ranking, saying it was bullish on…
hapabapa/iStock Editorial by way of Getty Photographs Gross sales from Eli Lilly’s (NYSE:LLY) newly permitted weight reduction treatment, Zepbound, may…
Most analysts predict the marketplace for new weight reduction medicine reminiscent of Wegovy and Mounjaro might be huge, however estimates…
Grandbrothers The U.S. Meals and Drug Administration (FDA) mentioned Monday that patisiran, a RNAi therapeutic developed by Alnylam Prescribed drugs…
Fotolia/iStock by way of Getty Pictures JPMorgan just lately raised its projections for weight reduction medication, anticipating the drug class…
juststock Mizuho downgraded BioXcel Therapeutics (NASDAQ:BTAI) to impartial and slashed its worth goal within the wake of the corporate’s Q2…
zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B – $5B…